[HTML][HTML] DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
Mitotic cell division increases tumour mutation burden and copy number load, predictive
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
H Jung, HS Kim, JY Kim, JM Sun… - Nature …, 2019 - ui.adsabs.harvard.edu
Mitotic cell division increases tumour mutation burden and copy number load, predictive
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
H Jung, HS Kim, JY Kim, JM Sun… - Nature …, 2019 - pubmed.ncbi.nlm.nih.gov
Mitotic cell division increases tumour mutation burden and copy number load, predictive
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
H Jung, HS Kim, JY Kim, JM Sun… - Nature …, 2019 - mdanderson.elsevierpure.com
Mitotic cell division increases tumour mutation burden and copy number load, predictive
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
H Jung, HS Kim, JY Kim, JM Sun, JS Ahn… - Nature …, 2019 - econpapers.repec.org
Mitotic cell division increases tumour mutation burden and copy number load, predictive
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
H Jung, HS Kim, JY Kim, JM Sun, JS Ahn… - Nature …, 2019 - ideas.repec.org
Mitotic cell division increases tumour mutation burden and copy number load, predictive
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load.
H Jung, HS Kim, JY Kim, JM Sun, JS Ahn… - Nature …, 2019 - europepmc.org
Mitotic cell division increases tumour mutation burden and copy number load, predictive
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
[HTML][HTML] DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
H Jung, HS Kim, JY Kim, JM Sun, JS Ahn… - Nature …, 2019 - ncbi.nlm.nih.gov
Mitotic cell division increases tumour mutation burden and copy number load, predictive
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
H Jung, HS Kim, JY Kim, JM Sun, JS Ahn… - NATURE …, 2019 - koasas.kaist.ac.kr
Mitotic cell division increases tumour mutation burden and copy number load, predictive
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic …
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
H Jung, HS Kim, JY Kim, JM Sun, JS Ahn… - Nature …, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Mitotic cell division increases tumour mutation
burden and copy number load, predictive markers of the clinical benefit of immunotherapy …
burden and copy number load, predictive markers of the clinical benefit of immunotherapy …